Publicaciones en las que colabora con Mar Castellanos Rodrigo (34)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

2023

  1. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

  2. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

    Neurologia, Vol. 37, Núm. 2, pp. 136-150

2021

  1. Delayed Neurological Improvement After Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke

    Stroke, Vol. 52, Núm. 7, pp. 2210-2217

  2. Impact of Mediterranean Diet prior to Stroke on the Prognosis of Patients Undergoing Endovascular Treatment

    Cerebrovascular Diseases, Vol. 50, Núm. 3, pp. 303-309

  3. Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution

    Neurologia, Vol. 36, Núm. 5, pp. 377-387

  4. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  5. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

  6. Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group

    Neurologia, Vol. 36, Núm. 6, pp. 462-471

  7. Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology

    Neurologia, Vol. 36, Núm. 4, pp. 305-323

  8. Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease

    Neurologia, Vol. 36, Núm. 1, pp. 1-8

2020

  1. Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain

    European Journal of Neurology, Vol. 27, Núm. 12, pp. 2491-2498

  2. Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain

    International Journal of Stroke, Vol. 15, Núm. 7, pp. 755-762

  3. Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

    Frontiers in Neurology, Vol. 11

  4. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

    Neurological Research and Practice, Vol. 2, Núm. 1

  5. Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey

    Neurologia, Vol. 35, Núm. 4, pp. 252-257

2019

  1. Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: Insights from the randomized URICO-ICTUS Trial

    Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 171-177

2018

  1. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335